Literature DB >> 30778704

Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.

Ariana von Lersner1, Lenny Droesen2,3, Andries Zijlstra4,5,6.   

Abstract

In epithelial-derived cancers, altered regulation of cell-cell adhesion facilitates the disruption of tissue cohesion that is central to the progression to malignant disease. Although numerous intercellular adhesion molecules participate in epithelial adhesion, the immunoglobulin superfamily (IgSF) member activated leukocyte cell adhesion molecule (ALCAM), has emerged from multiple independent studies as a central contributor to tumor progression. ALCAM is an archetypal member of the IgSF with conventional organization of five Ig-like domains involved in homo- and heterotypic adhesions. Like many IgSF members, ALCAM is broadly expressed and involved in cellular adhesion across many cellular processes. While the redundancy of intercellular adhesion molecules (CAMs) could diminish the impact of any single CAM, consistent correlation between ALCAM expression and patient outcome for multiple cancers underscores its role in tumor progression. Unlike most oncogenes and tumor suppressors, ALCAM is neither mutated nor amplified or deleted. Experimental disruption of ALCAM-mediated adhesions implies that this IgSF member contributes to tumor progression through dynamic turnover of the protein at the cell surface. Since ALCAM is not frequently altered at the gene level, it appears to promote malignant behavior through regulation of its availability rather than its specific activity. These observations help explain its heterogeneous expression within malignant disease and the drastic changes in protein levels across tumor progression. To reveal how ALCAM contributes to tumor progression, we review regulation of its gene expression, alternative splicing, targeted proteolysis, binding partners, and surface shedding within the context of cancer. Studying ALCAM regulation has led to a novel understanding of the fine-tuning of cell adhesive state through the utilization of otherwise normal regulatory processes, which thereby enable tumor cell invasion and metastasis.

Entities:  

Keywords:  ALCAM/CD166 alternative splicing; ALCAM/CD166 regulation; CAM regulation; Cell adhesion; Dynamic cell adhesion

Mesh:

Substances:

Year:  2019        PMID: 30778704      PMCID: PMC6639050          DOI: 10.1007/s10585-019-09957-2

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  64 in total

1.  Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.

Authors:  Sarah Minner; Franziska Kraetzig; Michael Tachezy; Ergin Kilic; Markus Graefen; Waldemar Wilczak; Carsten Bokemeyer; Hartwig Huland; Guido Sauter; Thorsten Schlomm
Journal:  Hum Pathol       Date:  2011-06-17       Impact factor: 3.466

2.  Characterization of cancer stem cells from different grades of human colorectal cancer.

Authors:  J Manhas; A Bhattacharya; S K Agrawal; B Gupta; P Das; S V S Deo; S Pal; S Sen
Journal:  Tumour Biol       Date:  2016-08-09

3.  Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

Authors:  A Lugli; G Iezzi; I Hostettler; M G Muraro; V Mele; L Tornillo; V Carafa; G Spagnoli; L Terracciano; I Zlobec
Journal:  Br J Cancer       Date:  2010-07-06       Impact factor: 7.640

4.  The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis.

Authors:  Chee Wai Wong; Danielle E Dye; Deirdre R Coombe
Journal:  Int J Cell Biol       Date:  2012-01-09

5.  CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.

Authors:  Marta I Oliveira; Carine M Gonçalves; Mafalda Pinto; Stéphanie Fabre; Ana Mafalda Santos; Simon F Lee; Mónica A A Castro; Raquel J Nunes; Rita R Barbosa; Jane R Parnes; Chao Yu; Simon J Davis; Alexandra Moreira; Georges Bismuth; Alexandre M Carmo
Journal:  Eur J Immunol       Date:  2011-11-28       Impact factor: 5.532

6.  Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.

Authors:  Piotr Donizy; Marcin Zietek; Agnieszka Halon; Marek Leskiewicz; Cyprian Kozyra; Rafal Matkowski
Journal:  Diagn Pathol       Date:  2015-07-02       Impact factor: 2.644

7.  Functional role of endothelial adhesion molecules in the early stages of brain metastasis.

Authors:  Manuel Sarmiento Soto; Sébastien Serres; Daniel C Anthony; Nicola R Sibson
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

8.  Cancer stem-like cell related protein CD166 degrades through E3 ubiquitin ligase CHIP in head and neck cancer.

Authors:  Meng Xiao; Ming Yan; Jianjun Zhang; Qin Xu; Shengcai Qi; Xu Wang; Wantao Chen
Journal:  Exp Cell Res       Date:  2017-03-06       Impact factor: 3.905

Review 9.  Integrins.

Authors:  Malgorzata Barczyk; Sergio Carracedo; Donald Gullberg
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

10.  CD166/ALCAM expression is characteristic of tumorigenicity and invasive and migratory activities of pancreatic cancer cells.

Authors:  Kenji Fujiwara; Kenoki Ohuchida; Masafumi Sada; Kohei Horioka; Charles D Ulrich; Koji Shindo; Takao Ohtsuka; Shunichi Takahata; Kazuhiro Mizumoto; Yoshinao Oda; Masao Tanaka
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more
  17 in total

1.  Molecules in metastasis.

Authors:  Jonathan P Sleeman
Journal:  Clin Exp Metastasis       Date:  2019-04       Impact factor: 5.150

2.  Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer, a pivotal link to clinical outcome and vascular embolism.

Authors:  Yiming Yang; Andrew J Sanders; Fiona Ruge; Xuefei Dong; Yuxin Cui; Qing Ping Dou; Shuqin Jia; Chunyi Hao; Jiafu Ji; Wen G Jiang
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

3.  Neural cell adhesion molecule is required for ventricular conduction system development.

Authors:  Camila Delgado; Lei Bu; Jie Zhang; Fang-Yu Liu; Joseph Sall; Feng-Xia Liang; Andrew J Furley; Glenn I Fishman
Journal:  Development       Date:  2021-06-07       Impact factor: 6.862

4.  ALCAM-EGFR interaction regulates myelomagenesis.

Authors:  Hongmei Luo; Dan Zhang; Fangfang Wang; Qiang Wang; Yu Wu; Maling Gou; Yiguo Hu; Wenyan Zhang; Jingcao Huang; Yuping Gong; Ling Pan; Tianshu Li; Pan Zhao; Danfeng Zhang; Ying Qu; Zhigang Liu; Tao Jiang; Yang Dai; Tingting Guo; Jiang Zhu; Lingqun Ye; Li Zhang; Weiping Liu; Qing Yi; Yuhuan Zheng
Journal:  Blood Adv       Date:  2021-12-14

5.  ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation.

Authors:  Bas Brinkhof; Bo Zhang; Zhanfeng Cui; Hua Ye; Hui Wang
Journal:  Gene X       Date:  2020-03-14

6.  Overexpression of miR-483-5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma.

Authors:  Luis Jaime Castro-Vega; Bruna Calsina; Nelly Burnichon; Tom Drossart; Ángel M Martínez-Montes; Virginie Verkarre; Laurence Amar; Jérôme Bertherat; Cristina Rodríguez-Antona; Judith Favier; Mercedes Robledo; Anne-Paule Gimenez-Roqueplo
Journal:  Clin Transl Med       Date:  2020-12

7.  ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium.

Authors:  Justine Münsterberg; Desirée Loreth; Laura Brylka; Stefan Werner; Jana Karbanova; Monja Gandrass; Svenja Schneegans; Katharina Besler; Fabienne Hamester; José Ramon Robador; Alexander Thomas Bauer; Stefan Werner Schneider; Michaela Wrage; Katrin Lamszus; Jakob Matschke; Yogesh Vashist; Güntac Uzunoglu; Stefan Steurer; Andrea Kristina Horst; Leticia Oliveira-Ferrer; Markus Glatzel; Thorsten Schinke; Denis Corbeil; Klaus Pantel; Cecile Maire; Harriet Wikman
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

8.  Biomarkers of tumor invasiveness in proteomics (Review).

Authors:  Daniel L Pouliquen; Alice Boissard; Olivier Coqueret; Catherine Guette
Journal:  Int J Oncol       Date:  2020-05-28       Impact factor: 5.650

9.  Multifaceted effects of soluble human CD6 in experimental cancer models.

Authors:  Inês T Simões; Fernando Aranda; Sergi Casadó-Llombart; María Velasco-de Andrés; Cristina Català; Pilar Álvarez; Marta Consuegra-Fernández; Marc Orta-Mascaró; Ramón Merino; Jesús Merino; José Alberola-Ila; Gloria González-Aseguinolaza; Esther Carreras; Vanesa Martínez; Francisco Lozano
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

10.  Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis.

Authors:  Yanli Liu; Shengying Liang; Fen Yang; Yuliang Sun; Lidan Niu; Yakun Ren; Hongmei Wang; Yanan He; Jiang Du; Jun Yang; Juntang Lin
Journal:  Stem Cell Res Ther       Date:  2020-08-08       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.